Skip to main content
Erschienen in: World Journal of Urology 10/2018

03.05.2018 | Original Article

Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR)

verfasst von: L. García-Aparicio, E. Blázquez-Gómez, O. Martin, S. Pérez-Bertólez, J. Arboleda, A. Soria, X. Tarrado

Erschienen in: World Journal of Urology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare the radiological and clinical outcomes of endoscopic treatment of primary VUR using polyacrylate-polyalcohol copolymer (PPC-Vantris®) or dextranomer-hyaluronic acid copolymer (Dx/HA-Deflux®).

Materials and methods

From October 2014 to April 2017, patients with primary VUR grade III to V that needed endoscopic treatment (ET) were eligible for this randomized clinical trial. We excluded toilet-trained patients with lower urinary tract symptoms. Patients were randomized and allocated into two groups: PPC group and Dx/HA group. After endoscopic treatment a voiding cystourethrography (VCUG) was performed at 6 months; if VUR was still present a second ET was performed. Radiological success was considered if postoperative VUR grade was 0 and clinical success rate was considered if no more fUTI appeared during follow-up.

Results

Forty-six patients were eligible but 2 did not accept the trial. Forty-four patients with 73 refluxing ureters were included. PPC: 34 refluxing ureters; and Dx/HA: 39 refluxing ureters. Both groups were statistically homogeneous and comparable. Mean follow-up was 27.6 months. Radiological success rate (82.2%) and clinical success rate (92.3%) were similar in both groups (p > 0.05). The volume of bulking agent used in those successfully treated was greater in Dx/HA group (p < 0.05). Distal ureter was excise in all cases of ureteral reimplantation after PPC treatment; however, distal ureter was preserved in all ureters reimplanted after Dx/HA injection.

Conclusion

PPC and Dx/HA had similar outcomes, but we must warn that ureteral reimplantation after endoscopic treatment with PPC is difficult because of the periureteral fibrosis.
Literatur
1.
Zurück zum Zitat Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz H (2004) The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171:2413CrossRef Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz H (2004) The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171:2413CrossRef
2.
Zurück zum Zitat Läckgren G, Wählin N (2001) Sk€oldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166:1887–1892CrossRef Läckgren G, Wählin N (2001) Sk€oldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166:1887–1892CrossRef
3.
Zurück zum Zitat García-Aparicio L, Blázquez-Gómez E, Vila Santandreu A, Camacho JA, Vila-Cots J, Ramos M et al (2016) Routine delayed voiding cystourethography after successful endoscopic treatment with Dx/HA of vesicoureteral reflux. Is it necessary? Actas Urol Esp 40(10):635–639CrossRef García-Aparicio L, Blázquez-Gómez E, Vila Santandreu A, Camacho JA, Vila-Cots J, Ramos M et al (2016) Routine delayed voiding cystourethography after successful endoscopic treatment with Dx/HA of vesicoureteral reflux. Is it necessary? Actas Urol Esp 40(10):635–639CrossRef
4.
Zurück zum Zitat Lee EK, Gatti JM, Demarco RT et al (2009) Long-term follow-up of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued follow-up. J Urol 181:1869–1874CrossRef Lee EK, Gatti JM, Demarco RT et al (2009) Long-term follow-up of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued follow-up. J Urol 181:1869–1874CrossRef
5.
Zurück zum Zitat Ormaechea M, Ruiz E, Denes E et al (2010) New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children. J Urol 183:714–717CrossRef Ormaechea M, Ruiz E, Denes E et al (2010) New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children. J Urol 183:714–717CrossRef
6.
Zurück zum Zitat Chertin B, Arafeh WA, Zeldin A et al (2011) Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris): surgical outcome following single injection. J Pediatr Urol 7:654–657CrossRef Chertin B, Arafeh WA, Zeldin A et al (2011) Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris): surgical outcome following single injection. J Pediatr Urol 7:654–657CrossRef
7.
Zurück zum Zitat Sharifiaghdas F, Tajalli F, Otukesh H, Shamsabadi RH (2014) Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up. J Pediatr Urol 10:1032–1369CrossRef Sharifiaghdas F, Tajalli F, Otukesh H, Shamsabadi RH (2014) Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up. J Pediatr Urol 10:1032–1369CrossRef
8.
Zurück zum Zitat Chertin B, Arafeh WA, Zeldin A, Ostrovsky IA, Kocherov S (2013) Endoscopic correction of VUR using Vantris as a new non-biodegradable tissue augmenting substance: three years of prospective follow-up. Urology 82:201–204CrossRef Chertin B, Arafeh WA, Zeldin A, Ostrovsky IA, Kocherov S (2013) Endoscopic correction of VUR using Vantris as a new non-biodegradable tissue augmenting substance: three years of prospective follow-up. Urology 82:201–204CrossRef
9.
Zurück zum Zitat Warchol S, Krzemien G, Szmigielska A, Bombinski P, Brzewski M, Dudek-Warchol T (2016) Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris). J Pediatr Urol 12(4):256.e1–256.e4CrossRef Warchol S, Krzemien G, Szmigielska A, Bombinski P, Brzewski M, Dudek-Warchol T (2016) Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris). J Pediatr Urol 12(4):256.e1–256.e4CrossRef
10.
Zurück zum Zitat Taşkinlar H, Avlan D, Bahadir GB, Delibaş A, Nayci A (2016) The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux. Int Braz J Urol 42(3):514–520CrossRef Taşkinlar H, Avlan D, Bahadir GB, Delibaş A, Nayci A (2016) The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux. Int Braz J Urol 42(3):514–520CrossRef
11.
Zurück zum Zitat Kocaoglu C (2016) Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children. J Pediatr Surg 51(10):1711–1715CrossRef Kocaoglu C (2016) Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children. J Pediatr Surg 51(10):1711–1715CrossRef
12.
Zurück zum Zitat Karakus SC, User İR, Kılıc BD, Akçaer V, Ceylan H, Ozokutan BH (2016) The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux. J Pediatr Surg 51(9):1496–1500CrossRef Karakus SC, User İR, Kılıc BD, Akçaer V, Ceylan H, Ozokutan BH (2016) The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux. J Pediatr Surg 51(9):1496–1500CrossRef
13.
Zurück zum Zitat Matouschek E (1981) Treatment of vesicorenal reflux by transurethral teflon-injection (author’s transl). Urol A 20(5):263–264 Matouschek E (1981) Treatment of vesicorenal reflux by transurethral teflon-injection (author’s transl). Urol A 20(5):263–264
14.
Zurück zum Zitat García-Aparicio L, Rodo J, Palazon P, Martín O, Blázquez-Gómez E, Manzanares A et al (2013) Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage. J Pediatr Urol 9(4):493–497CrossRef García-Aparicio L, Rodo J, Palazon P, Martín O, Blázquez-Gómez E, Manzanares A et al (2013) Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage. J Pediatr Urol 9(4):493–497CrossRef
15.
Zurück zum Zitat Alizadeh F, Mazdak H, Khorrami MH, Khalighinejad P, Shoureshi P (2013) Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer (Vantris®). J Pediatr Urol 9(4):488–492CrossRef Alizadeh F, Mazdak H, Khorrami MH, Khalighinejad P, Shoureshi P (2013) Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer (Vantris®). J Pediatr Urol 9(4):488–492CrossRef
16.
Zurück zum Zitat Kocherov S, Ulman I, Nikolaev S, Corbetta JP, Rudin Y, Slavkovic A et al (2014) Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris). Urology 84(3):689–693CrossRef Kocherov S, Ulman I, Nikolaev S, Corbetta JP, Rudin Y, Slavkovic A et al (2014) Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris). Urology 84(3):689–693CrossRef
Metadaten
Titel
Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR)
verfasst von
L. García-Aparicio
E. Blázquez-Gómez
O. Martin
S. Pérez-Bertólez
J. Arboleda
A. Soria
X. Tarrado
Publikationsdatum
03.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 10/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2314-7

Weitere Artikel der Ausgabe 10/2018

World Journal of Urology 10/2018 Zur Ausgabe

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.